Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

During the Trading Day
7.90 -0.37 / -4.47%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.90 0.00 / 0.00%
Volume: 53.8K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Revenue and IncomeNet Revenues30.4M18.7M43.4M20.8M
Cost of Goods Sold5.7M6.1M7.7M5.8M
Depreciation And Amortization458.0K421.0K395.0K402.0K
Operating ExpensesGross Income24.2M12.2M35.2M14.6M
General Expenses28.1M26.1M31.0M37.8M
Research And Development19.7M16.7M21.2M27.6M
Total Operating Expenses34.2M32.6M39.2M44.0M
Non-Operating ExpensesOperating Income-3.9M-13.9M4.2M-23.2M
Interest Expense On Debt1.4M1.3M1.3M1.3M
Other Expenses-45.0K0.000.000.00
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.3M-15.1M3.0M-24.5M
Net Income-5.3M-15.1M3.0M-24.5M
Shares To Calculate EPSShares To Calculate EPS124.3M125.3M126.1M126.9M
Shares To Calculate EPS Diluted124.3M125.3M134.5M126.9M
Earnings Per ShareEPS-$0.04-$0.12$0.02-$0.19
EPS Diluted-$0.04-$0.12$0.02-$0.19